{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T19:48:00Z","timestamp":1782157680424,"version":"3.54.5"},"reference-count":49,"publisher":"American Diabetes Association","issue":"7","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"name":"Ministry of Science, Innovation and Technological Development of the Republic of Serbia","award":["451-03-136\/2025-03\/ 200007"],"award-info":[{"award-number":["451-03-136\/2025-03\/ 200007"]}]},{"DOI":"10.13039\/501100016047","name":"Science Fund of the Republic of Serbia","doi-asserted-by":"publisher","award":["7742898"],"award-info":[{"award-number":["7742898"]}],"id":[{"id":"10.13039\/501100016047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Reduction in intestinal type 3 innate lymphoid cells (ILC3) frequency is associated with type 1 diabetes (T1D) pathogenesis in humans and in animal models. The current study showed that, after T1D induction by multiple\u2013low-dose streptozotocin in male C57BL\/6 mice, ILC3 were reduced in both blood and pancreas and produced less IL-22 and IL-2, and a decreased proportion expressed the gut-homing \u03b14\u03b27 integrin in the pancreas. Additionally, T1D induction in ILC3-impaired mice produced exacerbated hyperglycemia. To activate ILC3, Compound 1 (Cpd1), a synthetic selective free fatty acid receptor 2 (FFAR2) agonist, was administered orally in a prophylactic regimen, at early therapeutic stages, or during established disease, resulting in significant amelioration of T1D symptoms. Cpd1 upregulated ILC3 and activated regulatory T cells (Treg) within the small intestine lamina propria and the pancreas, enhanced intestinal barrier integrity, and increased microbial diversity. Cpd1 also reduced \u03b14\u03b27-expressing inflammatory cells in the pancreas while promoting the accumulation of gut-imprinted ILC3. IL-22 was important for this anti-inflammatory response, as treatment efficacy was inhibited when mice were additionally given neutralizing anti-IL-22 antibodies. Of note, NOD mice receiving Cpd1 exhibited postponed disease initiation, but the incidence of disease was similar to that of the control group. Overall, activation of intestinal ILC3 and Treg via FFAR2 engagement, and translation of these anti-inflammatory effects to the pancreas, provided significant benefit in a mouse T1D model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Article Highlights<\/jats:title>\n                    <jats:p>Modulating the adaptive immune response alone is insufficient for effective type 1 diabetes treatment. This study investigates targeting intestinal type 3 innate lymphoid cells as a novel therapeutic approach for type 1 diabetes. A synthetic free fatty acid receptor 2 agonist, Compound 1, activates intestinal IL-2+ and IL-22+ type 3 innate lymphoid cells and thereby reduces pancreatic inflammation, stabilizes intestinal barrier, and improves clinical outcomes in a type 1 diabetes mouse model. Compound 1 demonstrates therapeutic potential and may serve as a candidate for future clinical trials in type 1 diabetes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/db25-0742","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T15:14:26Z","timestamp":1779117266000},"page":"1221-1232","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":0,"title":["Activation of Intestinal Type 3 Innate Lymphoid Cells and Regulatory T Cells Through Free Fatty Acid Receptor 2 Ameliorates Type 1 Diabetes in Mice"],"prefix":"10.2337","volume":"75","author":[{"given":"Ivan","family":"Koprivica","sequence":"first","affiliation":[{"name":"Department of Immunology, Institute for Biological Research \u201cSini\u0161a Stankovi\u0107\u201d - National Institute of the Republic of Serbia, University of Belgrade 1 , Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalija","family":"Joni\u0107","sequence":"additional","affiliation":[{"name":"Department of Immunology, Institute for Biological Research \u201cSini\u0161a Stankovi\u0107\u201d - National Institute of the Republic of Serbia, University of Belgrade 1 , Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Dimitrijevi\u0107","sequence":"additional","affiliation":[{"name":"Department of Immunology, Institute for Biological Research \u201cSini\u0161a Stankovi\u0107\u201d - National Institute of the Republic of Serbia, University of Belgrade 1 , Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojan","family":"Jevti\u0107","sequence":"additional","affiliation":[{"name":"Department of Immunology, Institute for Biological Research \u201cSini\u0161a Stankovi\u0107\u201d - National Institute of the Republic of Serbia, University of Belgrade 1 , Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragica","family":"Mi\u0107anovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Immunology, Institute for Biological Research \u201cSini\u0161a Stankovi\u0107\u201d - National Institute of the Republic of Serbia, University of Belgrade 1 , Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goran","family":"Stegnjai\u0107","sequence":"additional","affiliation":[{"name":"Department of Immunology, Institute for Biological Research \u201cSini\u0161a Stankovi\u0107\u201d - National Institute of the Republic of Serbia, University of Belgrade 1 , Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica","family":"Lazarevi\u0107","sequence":"additional","affiliation":[{"name":"Department of Immunology, Institute for Biological Research \u201cSini\u0161a Stankovi\u0107\u201d - National Institute of the Republic of Serbia, University of Belgrade 1 , Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzana","family":"Stanisavljevi\u0107","sequence":"additional","affiliation":[{"name":"Department of Immunology, Institute for Biological Research \u201cSini\u0161a Stankovi\u0107\u201d - National Institute of the Republic of Serbia, University of Belgrade 1 , Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Pilipovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Immunology, Institute for Biological Research \u201cSini\u0161a Stankovi\u0107\u201d - National Institute of the Republic of Serbia, University of Belgrade 1 , Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nata\u0161a","family":"Radulovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Immunology, Institute for Biological Research \u201cSini\u0161a Stankovi\u0107\u201d - National Institute of the Republic of Serbia, University of Belgrade 1 , Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Saksida","sequence":"additional","affiliation":[{"name":"Department of Immunology, Institute for Biological Research \u201cSini\u0161a Stankovi\u0107\u201d - National Institute of the Republic of Serbia, University of Belgrade 1 , Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danijela","family":"Mi\u0161i\u0107","sequence":"additional","affiliation":[{"name":"Department of Plant Physiology, Institute for Biological Research \u201cSini\u0161a Stankovi\u0107\u201d - National Institute of the Republic of Serbia, University of Belgrade 2 , Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Zdravkovi\u0107","sequence":"additional","affiliation":[{"name":"Endocrinology Department, University Children's Hospital 3 , Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade 4 , Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Fraser","sequence":"additional","affiliation":[{"name":"Epics Therapeutics S.A. 5 , Gosselies, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0110or\u0111e","family":"Miljkovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Immunology, Institute for Biological Research \u201cSini\u0161a Stankovi\u0107\u201d - National Institute of the Republic of Serbia, University of Belgrade 1 , Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8542-1327","authenticated-orcid":false,"given":"Ivana","family":"Stojanovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Immunology, Institute for Biological Research \u201cSini\u0161a Stankovi\u0107\u201d - National Institute of the Republic of Serbia, University of Belgrade 1 , Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"2026062214520821400_B1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2337\/db15-0779","article-title":"Insulitis and \u03b2-cell mass in the natural history of type 1 diabetes","volume":"65","author":"Campbell-Thompson","year":"2016","journal-title":"Diabetes"},{"key":"2026062214520821400_B2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41422-020-0323-8","article-title":"Innate lymphoid cells control signaling circuits to regulate tissue-specific immunity","volume":"30","author":"Klose","year":"2020","journal-title":"Cell Res"},{"key":"2026062214520821400_B3","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"key":"2026062214520821400_B4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41419-019-1540-2","article-title":"ILC3 function as a double-edged sword in inflammatory bowel diseases","volume":"10","author":"Zeng","year":"2019","journal-title":"Cell Death Dis"},{"key":"2026062214520821400_B5","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/s41590-019-0425-y","article-title":"Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues","volume":"20","author":"Cella","year":"2019","journal-title":"Nat Immunol"},{"key":"2026062214520821400_B6","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2019.09.014","article-title":"Metabolite-sensing receptor Ffar2 regulates colonic group 3 innate lymphoid cells and gut immunity","volume":"51","author":"Chun","year":"2019","journal-title":"Immunity"},{"key":"2026062214520821400_B7","doi-asserted-by":"crossref","first-page":"jem.20190489","DOI":"10.1084\/jem.20190489","article-title":"Acetate coordinates neutrophil and ILC3 responses against C. difficile through FFAR2","volume":"217","author":"Fachi","year":"2020","journal-title":"J Exp Med"},{"key":"2026062214520821400_B8","doi-asserted-by":"crossref","first-page":"1249288","DOI":"10.1126\/science.1249288","article-title":"Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis","volume":"343","author":"Mortha","year":"2014","journal-title":"Science"},{"key":"2026062214520821400_B9","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/JLB.5MA0120-209R","article-title":"Distinct and shared gene expression for human innate versus adaptive helper lymphoid cells","volume":"108","author":"Ercolano","year":"2020","journal-title":"J Leukoc Biol"},{"key":"2026062214520821400_B10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature12240","article-title":"Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria","volume":"498","author":"Hepworth","year":"2013","journal-title":"Nature"},{"key":"2026062214520821400_B11","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41586-022-05141-x","article-title":"ILC3s select microbiota-specific regulatory T cells to establish tolerance in the gut","volume":"610","author":"Lyu","year":"2022","journal-title":"Nature"},{"key":"2026062214520821400_B12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-019-1082-x","article-title":"Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2","volume":"568","author":"Zhou","year":"2019","journal-title":"Nature"},{"key":"2026062214520821400_B13","first-page":"679","article-title":"Intestinal epithelial cell regulation of adaptive immune dysfunction in human type 1 diabetes","volume":"7","author":"Graves","year":"2016","journal-title":"Front Immunol"},{"key":"2026062214520821400_B14","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.3390\/molecules28083366","article-title":"Development of type 1 diabetes in mice is associated with a decrease in IL-2-producing ILC3 and FoxP3+ Treg in the small intestine","volume":"28","author":"Saksida","year":"2023","journal-title":"Molecules"},{"key":"2026062214520821400_B15","doi-asserted-by":"crossref","first-page":"2297872","DOI":"10.1080\/19490976.2023.2297872","article-title":"Hyperbaric oxygen augments susceptibility to C. difficile infection by impairing gut microbiota ability to stimulate the HIF-1\u03b1-IL-22 axis in ILC3","volume":"16","author":"Fachi","year":"2024","journal-title":"Gut Microbes"},{"key":"2026062214520821400_B16","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1021\/acs.jafc.9b07701","article-title":"Butyrate ameliorates antibiotic-driven type 1 diabetes in the female offspring of nonobese diabetic mice","volume":"68","author":"Jia","year":"2020","journal-title":"J Agric Food Chem"},{"key":"2026062214520821400_B17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00125-019-05073-8","article-title":"Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial","volume":"63","author":"de Groot","year":"2020","journal-title":"Diabetologia"},{"key":"2026062214520821400_B18","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1084\/jem.20080034","article-title":"In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ ROR\u03b3t+ T cells","volume":"205","author":"Lochner","year":"2008","journal-title":"J Exp Med"},{"key":"2026062214520821400_B19","volume-title":"Guide for the Care and Use of Laboratory Animals.","author":"National Research Council of the National Academies","year":"2011","edition":"8th ed"},{"key":"2026062214520821400_B20","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/ame2.70050","article-title":"Multiple low dose streptozotocin-induced diabetes as a model for studying autoimmune diabetes in humans","volume":"8","author":"Koprivica","year":"2025","journal-title":"Animal Model Exp Med"},{"key":"2026062214520821400_B21","doi-asserted-by":"crossref","first-page":"120184","DOI":"10.1016\/j.lfs.2021.120184","article-title":"Phenethyl ester of rosmarinic acid attenuates autoimmune responses during type 1 diabetes development in mice","volume":"288","author":"Koprivica","year":"2022","journal-title":"Life Sci"},{"key":"2026062214520821400_B22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-4939-9936-1_17","article-title":"The effect of macrophage migration inhibitory factor on intestinal permeability: FITC-dextran serum measurement and transmission electron microscopy","volume":"2080","author":"Vuji\u010di\u0107","year":"2020","journal-title":"Methods Mol Biol"},{"key":"2026062214520821400_B23","doi-asserted-by":"crossref","first-page":"1454156","DOI":"10.3389\/fimmu.2024.1454156","article-title":"Novel AHR ligand AGT-5 ameliorates type 1 diabetes in mice through regulatory cell activation in the early phase of the disease","volume":"15","author":"Joni\u0107","year":"2024","journal-title":"Front Immunol"},{"key":"2026062214520821400_B24","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"2026062214520821400_B25","doi-asserted-by":"crossref","first-page":"103836","DOI":"10.1016\/j.jff.2020.103836","article-title":"Chokeberry (Aronia melanocarpa) fruit extract modulates immune response in vivo and in vitro","volume":"66","author":"Gaji\u0107","year":"2020","journal-title":"J Funct Foods"},{"key":"2026062214520821400_B26","doi-asserted-by":"crossref","first-page":"7136","DOI":"10.3390\/ijms25137136","article-title":"Anti-neuroinflammatory effects of a novel bile acid derivative","volume":"25","author":"Bjedov","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026062214520821400_B27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1530\/eje.0.1470543","article-title":"Efficacy of 1400 W, a novel inhibitor of inducible nitric oxide synthase, in preventing interleukin-1beta-induced suppression of pancreatic islet function in vitro and multiple low-dose streptozotocin-induced diabetes in vivo","volume":"147","author":"Rydgren","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"2026062214520821400_B28","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.1038\/s41598-018-24706-3","article-title":"The role of macrophage migration inhibitory factor in the function of intestinal barrier","volume":"8","author":"Vujicic","year":"2018","journal-title":"Sci Rep"},{"key":"2026062214520821400_B29","doi-asserted-by":"crossref","first-page":"e70350","DOI":"10.1002\/brb3.70350","article-title":"Amelioration of central nervous system autoimmunity through FFAR2 agonism is associated with changes in gut microbiota","volume":"15","author":"Jevti\u0107","year":"2025","journal-title":"Brain Behav"},{"key":"2026062214520821400_B30","doi-asserted-by":"crossref","first-page":"e1122","DOI":"10.1002\/cti2.1122","article-title":"Cytokines in type 1 diabetes: mechanisms of action and immunotherapeutic targets","volume":"9","author":"Lu","year":"2020","journal-title":"Clin Transl Immunology"},{"key":"2026062214520821400_B31","doi-asserted-by":"crossref","first-page":"653560","DOI":"10.3389\/fimmu.2021.653560","article-title":"Modulation of intestinal ILC3 for the treatment of type 1 diabetes","volume":"12","author":"Stojanovi\u0107","year":"2021","journal-title":"Front Immunol"},{"key":"2026062214520821400_B32","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/ni.3713","article-title":"Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes","volume":"18","author":"Mari\u00f1o","year":"2017","journal-title":"Nat Immunol"},{"key":"2026062214520821400_B33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0090-1229(88)90094-3","article-title":"Interleukin-2 production and interleukin-2 receptor expression in children with newly diagnosed diabetes","volume":"49","author":"Roncarolo","year":"1988","journal-title":"Clin Immunol Immunopathol"},{"key":"2026062214520821400_B34","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s001250050135","article-title":"Imbalance of the interleukin 2 system in children with IDDM","volume":"37","author":"Tomoda","year":"1994","journal-title":"Diabetologia"},{"key":"2026062214520821400_B35","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1038\/s41467-025-59626-0","article-title":"Immune perturbations in human pancreas lymphatic tissues prior to and after type 1 diabetes onset","volume":"16","author":"Golden","year":"2025","journal-title":"Nat Commun"},{"key":"2026062214520821400_B36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/imm.12867","article-title":"Harnessing the power of regulatory T-cells to control autoimmune diabetes: overview and perspective","volume":"153","author":"Yu","year":"2018","journal-title":"Immunology"},{"key":"2026062214520821400_B37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12974-024-03017-7","article-title":"Increased regulatory activity of intestinal innate lymphoid cells type 3 (ILC3) prevents experimental autoimmune encephalomyelitis severity","volume":"21","author":"Lazarevi\u0107","year":"2024","journal-title":"J Neuroinflammation"},{"key":"2026062214520821400_B38","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"key":"2026062214520821400_B39","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.cmet.2018.06.012","article-title":"Gut microbiota-stimulated innate lymphoid cells support \u03b2-defensin 14 expression in pancreatic endocrine cells, preventing autoimmune diabetes","volume":"28","author":"Miani","year":"2018","journal-title":"Cell Metab"},{"key":"2026062214520821400_B40","doi-asserted-by":"crossref","first-page":"15140","DOI":"10.1073\/pnas.1814558116","article-title":"Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes","volume":"116","author":"Sorini","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026062214520821400_B41","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1084\/jem.20150744","article-title":"Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to T1D onset","volume":"213","author":"Costa","year":"2016","journal-title":"J Exp Med"},{"key":"2026062214520821400_B42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.it.2025.10.009","article-title":"Interleukin-22: the hub bridging gut homeostasis and metabolism","volume":"47","author":"Wang","year":"2026","journal-title":"Trends Immunol"},{"key":"2026062214520821400_B43","doi-asserted-by":"crossref","first-page":"103090","DOI":"10.1016\/j.jaut.2023.103090","article-title":"Gut dysbiosis promotes islet-autoimmunity by increasing T-cell attraction in islets via CXCL10 chemokine","volume":"140","author":"P\u00f6ysti","year":"2023","journal-title":"J Autoimmun"},{"key":"2026062214520821400_B44","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.4049\/jimmunol.152.7.3282","article-title":"Role of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo","volume":"152","author":"Hamann","year":"1994","journal-title":"J Immunol"},{"key":"2026062214520821400_B45","doi-asserted-by":"crossref","first-page":"19120","DOI":"10.1038\/s41598-020-76109-y","article-title":"Butyrate induced Tregs are capable of migration from the GALT to the pancreas to restore immunological tolerance during type-1 diabetes","volume":"10","author":"Jacob","year":"2020","journal-title":"Sci Rep"},{"key":"2026062214520821400_B46","doi-asserted-by":"crossref","first-page":"eadi3624","DOI":"10.1126\/science.adi3624","article-title":"Neuronal-ILC2 interactions regulate pancreatic glucagon and glucose homeostasis","volume":"387","author":"\u0160estan","year":"2025","journal-title":"Science"},{"key":"2026062214520821400_B47","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1210\/me.2015-1007","article-title":"An acetate-specific GPCR, FFAR2, regulates insulin secretion","volume":"29","author":"Priyadarshini","year":"2015","journal-title":"Mol Endocrinol"},{"key":"2026062214520821400_B48","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/dom.13529","article-title":"Short chain fatty acids stimulate insulin secretion and reduce apoptosis in mouse and human islets in vitro: role of free fatty acid receptor 2","volume":"21","author":"Pingitore","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"2026062214520821400_B49","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.2337\/db15-0481","article-title":"Selective FFA2 agonism appears to act via intestinal PYY to reduce transit and food intake but does not improve glucose tolerance in mouse models","volume":"64","author":"Forbes","year":"2015","journal-title":"Diabetes"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/75\/7\/1221\/870676\/db250742.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/75\/7\/1221\/870676\/db250742.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T18:52:20Z","timestamp":1782154340000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/75\/7\/1221\/167033\/Activation-of-Intestinal-Type-3-Innate-Lymphoid"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":49,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,5,18]]},"published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db25-0742","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]}}}